Catalyst Wire Dossier Catalyst Wire Dossier

NORTREL 7/7/7 (28 DAY REGIMEN)

NORETHINDRONE AND ETHINYL ESTRADIOL · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NORTREL 7/7/7 (28 DAY REGIMEN), covering 2014-12-31 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: NORTREL 7/7/7 (28 DAY REGIMEN) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing